4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-059823
SVP & Chief Scientific Officer sold 396,323 shares at an average $29.00 ($11,493,476)
- SVP & Chief Scientific Officer acquired 396,323 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Doberstein Stephen K · SVP & Chief Scientific Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-06 | Exercise or conversion : show line 1 in the form | +20,914 | $9.53 | $199,310 | 52,016 | D |
| 2017-11-06 | Sale : show line 2 in the form | −20,914 | $24.98 | $522,432 | 31,102 | D |
| 2017-11-07 | Exercise or conversion : show line 3 in the form | +75,409 | $9.53 | $718,648 | 106,511 | D |
| 2017-11-07 | Sale : show line 4 in the form | −75,409 | $25.78 | $1,944,044 | 31,102 | D |
| 2017-11-08 | Exercise or conversion : show line 5 in the form | +300,000 | $9.53 | $2,859,000 | 331,102 | D |
| 2017-11-08 | Sale : show line 6 in the form | −300,000 | $30.09 | $9,027,000 | 31,102 | D |
| Open-market sales · 396,323 sh · avg $29.00 · $11,493,476 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-11-06 | Exercise or conversion : show line 7 in the form Stock Option | −20,914 | 375,409 | D |
| 2017-11-07 | Exercise or conversion : show line 8 in the form Stock Option | −75,409 | 300,000 | D |
| 2017-11-08 | Exercise or conversion : show line 9 in the form Stock Option | −300,000 | 0 | D |
Loading xslF345X03/doc4.xml…